证券代码： 301362 证券简称：民爆光电 深圳民爆光电股份有限公司投资者关系活动记录表 | 投资者关系活动 | 分析师会议 □√特定对象调研 □ | | --- | --- | | 类别 □ | 媒体采访 业绩说明会 □ | | □ | 新闻发布会 □ 路演活动 | | □ | 现场参观 | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 现场调研 | | 人员姓名 | 深圳含金量私募、前海恒邦股权投资、华西证券、轻舟资本、诚 | | | 泽资产共 7 人 | | 时间 | 年 月 日 下午 2025 6 9 (周一) 15:00-16:30 | | 地点 | 深圳市宝安区福永街道（福园一路西侧）润恒工业厂区 2 栋 5 楼 | | | 会议室 | | 上市公司接待人 | 董事、副总经理兼董事会秘书 黄金元 | | 员姓名 | 证券事务代表 李娜 | | | Q:现在美国关税战，对公司发展有影响吗？ | | | A：尊敬的投资者您好，2024 年度，公司直接和间接出口至美国 | | | 市场的产品占总收入的比例约为 7.3%，美国加征关税对公司的 | | | 经营影响很小。未来， ...

Company Overview - Beijing Ruimait Medical Technology Co., Ltd. specializes in the manufacturing of medical devices and consumables in the respiratory health sector, with key products including various types of sleep breathing machines and monitoring devices [2] - The company holds a total of 633 domestic patents, including 107 invention patents, 390 utility model patents, and 136 design patents, as well as 202 international patents across multiple countries [2] Financial Performance - For the first quarter of 2025, the company reported a revenue of 265 million yuan, representing a year-on-year increase of 38.11%, and a net profit of 71.93 million yuan, up 44.11% year-on-year, with a gross profit margin of 49.57% [2] Market Position - As of June 9, the company's stock closed at 84.6 yuan, down 1.12%, with a rolling price-to-earnings (PE) ratio of 42.73 times, and a total market capitalization of 7.58 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 50.64 times and a median of 37.05 times, Ruimait ranks 85th in terms of PE ratio [1][3] Shareholding Structure - As of the first quarter of 2025, a total of 14 institutions held shares in Ruimait, including 6 funds, 5 other institutions, 2 brokerages, and 1 social security fund, with a total holding of 26.92 million shares valued at 2.172 billion yuan [1]

Group 1 - The core viewpoint of the news is that Chao Yan Co., Ltd. has a high rolling price-to-earnings (PE) ratio of 70.66, significantly above the industry average of 50.64, indicating a premium valuation in the medical device sector [1][2] - As of June 9, the company's stock closed at 26.11 yuan, with a market capitalization of 11.184 billion yuan, reflecting a 1.28% increase [1] - The company has experienced a net outflow of main funds amounting to 245.27 million yuan on June 9, with a total outflow of 2,328.49 million yuan over the past five days [1] Group 2 - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, and X-ray equipment [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received a second-class award for national defense technology invention from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Group 3 - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 98.4324 million yuan, representing a year-on-year increase of 28.69%, and a net profit of 39.3220 million yuan, up 47.70% year-on-year, with a gross profit margin of 73.83% [1]

证券研究报告：金融工程报告 发布时间：2025-06-09 研究所 研究所 分析师:肖承志 SAC 登记编号:S1340524090001 Email:xiaochengzhi@cnpsec.com 研究助理:金晓杰 SAC 登记编号:S1340124100010 E研ma究il所:jinxiaojie@cnpsec.com 近期研究报告 近期研究报告 《结合基本面和量价特征的 GRU 模型》 - 2025.06.05 《DeepSeek-R1 完成小版本更新，阿里 开源自主搜索 AI 智能体——AI 动态汇 总 20250602》 - 2025.06.03 《Claude 4 系列发布，谷歌上线编程智 能体 Jules——AI 动态汇总 20250526》 - 2025.05.27 《谷歌发布智能体白皮书，Manus 全面 开放注册——AI 动态汇总 20250519》 - 2025.05.20 《证监会修改《重组办法》，深化并购重 组改革——微盘股指数周报 20250518》 - 2025.05.19 《通义千问发布Qwen-3模型，DeepSeek 发布数理证明大模型——AI 动态汇总 20250505 ...

【今日新股】 今日无新股申购，无新股上市。 •周五（2025年6月6日），港股三大指数集体走软，截止收盘，恒生指数跌0.48%或114.43点，报 23792.54点，全日成交额为2356.22亿港元；恒生国企指数跌0.63%，报8629.75点；恒生科技指数跌 0.63%，报5286.52点。全周来看，恒指累涨2.16%，国指累涨2.34%，恒科指累涨2.25%。 •周五（当地时间2025年6月6日），美股三大指数涨跌不一，截至收盘，道琼斯指数涨1.05%，报 42,762.87点；标普500指数涨1.03%，报6,000.36点；纳斯达克指数涨1.20%，报19,529.95点。 【隔夜行情】 •周五（2025年6月6日），A股三大指数涨跌不一，截至收盘，微涨0.04%，报3385.36点，实现"四连 涨"，周累计涨幅超1%。深证成指：下跌0.19%，报10183.7点。创业板指：下跌0.45%，报2039.44点； 北证50跌0.53%。成交缩量：两市成交额11,518亿–11,772亿元，较前一日减少约1,383亿–1,398亿元 【重要新闻】 【国家外汇管理局：截至5月末 我国外汇储备规模为3285 ...

南财早新闻，早听早知道。 今日关注 5、广东省广州市2025年首批配售型保障性住房选房顺序号摇号仪式6月7日举行，经公开摇号，萝岗和 苑项目1714户申请家庭与嘉翠苑项目715户申请家庭的选房顺序号已确定。 投资要闻 近日，多家知名外资机构上调中国经济增速预期和股指目标点位，表达对中国经济和中国资产的看好。 摩根士丹利宣布，上调中国股指的目标点位。高盛也发布研报称，鉴于人民币对美元汇率走强，维持对 中国股票的增持立场。机构认为，中国经济增长预期向好、企业盈利前景改善、中国资产估值相对较 低，增强了中国市场、中国资产对全球投资者的中长期吸引力。 宏观经济 1、6月8日是全国高考的第二天，随着下午外语科目考试结束，语文、数学、外语三门高考统考科目考 试全部结束。已有部分省份公布了高考成绩查询时间，湖南、湖北、吉林、江西等地，预计在6月25日 左右公布高考成绩。 2、国家统计局数据显示，1—4月规模以上工业中小企业增加值同比增长8.2%，营业收入达25.8万亿 元，其中装备制造业、原材料制造业因技术升级带动需求增长显著，31个制造业大类中28个实现增长。 3、据统计，全国至少已有27个省份在地方性法规中明确延长婚假 ...

因子拥挤度观察：小市值因子表现较好。 小市值因子拥挤度 1.05 ，低估值因子拥挤度 0.06 ，高盈利因 子拥挤度 -0.18 ，高盈利增长因子拥挤度 -0.23 。 行业拥挤度：机械设备、综合、商贸零售、环保和美容护理的行业拥挤度相对较高。 美容护理和银行的行 业拥挤度上升幅度相对较大。 报告导读： 从技术面来看， Wind 全 A 于 6 月 4 日突破 SAR 点位，发出做多信号；均 线强弱指数与顶部仍有一定的距离，证明指数仍有上行空间。因此，我们认为，市场下周 或将延续震荡上行态势。 下周市场观点：市场下周或将延续震荡上行态势。 从量化指标上看，基于沪深 300 指数的流动性冲击指 标周五为 0.30 ，高于前一周（ 0.13 ），意味着当前市场的流动性高于过去一年平均水平 0.30 倍标准 差。上证 50ETF 期权成交量的 PUT-CALL 比率震荡下降，周五为 0.85 ，低于前一周（ 1.15 ），投资 者对上证 50ETF 短期走势谨慎程度下降。上证综指和 Wind 全 A 五日平均换手率分别为 0.82% 和 1.40% ，处于 2005 年以来的 56.33% 和 68.58% 分位点 ...

点击注册小程序 查看完整报告 特别申明： 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客 户，用作新媒体形势下研究信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿 订阅、接收或使用本订阅号中的任何信息。本订阅号难以设置访问权限，若给您造成不便， 敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相关人员为光大 证券的客户。 报告摘要 大类因子表现： 本周（2025.06.03-2025.06.06，下同）beta因子和动量因子获得正收益（0.58%和0.31%）；规模因子和流 动性因子取得明显负收益（-0.66%和-0.37%），市场动量效应占优，小市值风格仍较为显著。 单因子表现： 沪深300股票池中，本周表现较好的因子有总资产增长率(2.23%)、单季度营业收入同比增长率(1.78%)、单 季度ROA(1.58%),表现较差的因子有净利润断层(-0.36%)、5日平均换手率(-0.51%)、市净率因子 (-0.64%)。 中证500股票池中，本周表现较好的因子有单季度净利润同比增长率(1.54%)、单季度营业利润同比增长率 (1.29%)、单季度RO ...

Group 1 - The Xinjiang Securities Regulatory Bureau is implementing a regular visiting mechanism to support listed companies in the region, addressing their difficulties and suggestions to promote high-quality development [1] - Since 2024, the bureau and local government have visited over 60% of listed companies, with 13 companies visited this year across various industries including manufacturing, mining, finance, and information technology [1] - A total of 17 issues and suggestions have been collected from these visits, covering industrial policies, corporate financing, and operational challenges, with 7 issues already resolved and 10 ongoing [1] Group 2 - The bureau emphasizes policy promotion, guiding listed companies to leverage new policies for value management through mergers, buybacks, dividends, and equity incentives [2] - As of now, 33 listed companies in the region have announced cash dividend plans totaling 11.608 billion yuan, representing 82.5% of profitable companies; 11 companies have conducted stock buybacks amounting to 1.224 billion yuan [2] - The bureau plans to deepen regulatory collaboration with local government, focusing on enhancing regulatory services and optimizing corporate governance to foster a virtuous cycle of regulatory guidance, value enhancement, and economic empowerment [2]

Core Viewpoint - The management of state-owned enterprises (SOEs) in China has shifted from policy advocacy to substantive implementation, with expectations for valuation restructuring and market confidence enhancement as assessment mechanisms and supporting policies improve [1][5]. Group 1: SOE Value Management - The State-owned Assets Supervision and Administration Commission (SASAC) has emphasized improving the quality of SOEs' listed companies and enhancing value management to stabilize market expectations [1][4]. - Several SOEs have held performance briefings and investor engagement activities, committing to increase dividend payouts and enhance shareholder returns while focusing on core business improvement and innovation [1][2]. - China National Nuclear Corporation (CNNC) reported a market value of approximately 260 billion yuan, with a year-on-year increase of over 30%, highlighting its commitment to shareholder value through strategic investments [1][2]. Group 2: Dividend Policies - China National Power has maintained a cash dividend payout ratio exceeding 35% for ten consecutive years, with the 2024 dividend ratio reaching a historical high of 41.92%, totaling over 24 billion yuan in cumulative dividends [2]. - China Nuclear Technology has consistently returned cash dividends for 18 years, with a 2024 payout ratio of 32.43% and an average payout ratio exceeding 30% from 2020 to 2024 [2]. - China Huaneng Group is focused on enhancing dividend frequency and amounts across its listed companies to stabilize market value [2]. Group 3: Innovation and Reform - Accelerating innovation and deepening reforms are crucial for SOEs to enhance value management and improve the quality of listed companies [3][4]. - The State Grid Corporation is implementing multiple measures to promote high-quality development of its listed companies, focusing on energy transition and new power system construction [3]. - China Aerospace Science and Technology Corporation aims to enhance innovation capabilities and integrate technology and industry innovation to improve value creation [3]. Group 4: Regulatory Framework - The SASAC has issued guidelines to improve the market value management of SOEs, emphasizing the importance of maintaining investor rights and promoting healthy capital market development [3][4]. - Recent analyses indicate that value management is essential for listed companies to enhance intrinsic value and market performance through various compliant methods [4][5]. - SOEs are increasingly formalizing their value management practices, including the establishment of value enhancement plans and regular communication with investors [5].